ICON CLINICAL RESEARCH LIMITED -  

Ranking results:

Past rankings:

2019
Criterium:Position:
Overall Score:> 1000
Total Number of Projects:> 1000
2018
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
2015
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2015-01-01 - 2022-12-31 ):

Total Project Funding:

Funding per Partner:

Projects:

Leadership:

Total number of projects: 6
As coordinator: 0
As participant: 6
Sole participant: 0
Coordinator / Participant Ratio: 0*

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2019 0 25.395.897 0 1
2018 0 8.265.128 1.277.000 2
2017 0 8.540.715 625.000 2
2015 0 5.980.435 659.105 1

Networking:

Partners:

Institution:Projects [No]:
ALTA RICERCA E SVILUPPO IN BIOTECNOLOGIE SRL ALTA2
CHARITE UNIVERSITAETSMEDIZIN BERLIN2
PLURISTEM2
THE UNIVERSITY OF SHEFFIELD2
UNIVERSITY COLLEGE DUBLIN2
AMGEN LIMITED1
ASHLAND SPECIALTIES IRELAND LIMITED1
ASKLEPIOS KLINIKEN HAMBURG1
ASSOCIATION GENETHON1
ASTRAZENECA1
BAYER1
BE THE PARTNER1
BE THE PARTNER INC1
BIOREPERIA AB1
BLAFAR LIMITED1
CENTRE HOSPITALIER UNIVERSITAIRE1
CENTRE HOSPITALIER UNIVERSITAIRE DE MONTPELLIER1
CHRISTIAN ALBRECHTS UNIVERSITAET ZU KIEL1
COMTRADE PROGRAMSKE RESITVE DOO1
CRESSET BIOMOLECULAR DISCOVERY LIMITED1
ECM INGENIERIA AMBIENTAL SL1
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE1
ERESEARCH TECHNOLOGY INC1
EXPERIMENTELLE PHARMAKOLOGIE UND ONKOLOGIE BERLINBUCH1
EYECRO LLC1
FONDAZIONE POLIAMBULANZA1
FRIEDRICHALEXANDERUNIVERSITAET ERLANGEN NUERNBERG1
FUNDACION PRIVADA INSTITUTO DE SALUD GLOBAL BARCELONA1
GENOME IDENTIFICATION DIAGNOSTICS1
GOETEBORGS UNIVERSITET1
GRUNENTHAL1
HGBEYOND MATERIALS SICENCE SL1
HUMANITAS MIRASOLE1
HUNTINGTON'S DISEASE ASSOCIATION OF IRELAND1
ICON CLINICAL RESEARCH1
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE1
INNOVATION ACTA1
INSERM TRANSFERT1
INTERNATIONAL OSTEOPOROSIS FOUNDATION1
IXSCIENT LIMITED1
KARLSRUHER INSTITUT FUER TECHNOLOGIE1
KATHOLIEKE UNIVERSITEIT LEUVEN1
KING'S COLLEGE LONDON1
LABORATORIO IBERICO INTERNACIONAL DE NANOTECNOLOGIA1
LINKOPINGS UNIVERSITET1
MCROBERTS BV1
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN1
MOTOR NEURONE DISEASE ASSOCIATION1
NATIONAL UNIVERSITY OF IRELAND GALWAY1
NATIONAL UNIVERSITY OF IRELAND MAYNOOTH1
NORGES TEKNISKNATURVITENSKAPELIGE UNIVERSITET NTNU1
NOVARTIS PHARMA1
OCUPHARM DIAGNOSTICS SL1
OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST1
PARACELSUS MEDIZINISCHE PRIVATUNIVERSITAT SALZBURG PRIVATSTIFTUNG1
PENUMOLOGISCHES FORSCHUNGSINSTITUTAN DER LUNGENCLINIC GROSSHANSDORF1
PFIZER LIMITED1
QUEEN MARY AND WESTFIELD COLLEGE UNIVERSITY OF LONDON1
REGION SYDDANMARK1
ROBERT BOSCH GESELLSCHAFT FUR MEDIZINISCHE FORSCHUNG MBH1
SANOFIAVENTIS1
TAKEDA DEVELOPMENT CENTRE EUROPE1
TAKEDA PHARMACEUTICALS INTERNATIONAL1
TECHNISCHE UNIVERSITAET DRESDEN1
TEVA PHARMACEUTICAL INDUSTRIES LIMITED1
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD1
THE FOUNDATION FOR MEDICAL RESEARCH INFRASTRUCTURAL DEVELOPMENT AND HEALTH SERVICES NEXT TO THE MEDICAL CENTER TEL AVIV1
THE PROVOST FELLOWS FOUNDATION SCHOLARS & THE OTHER MEMBERS OF BOARD OF THE COLLEGE OF THE HOLY & UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN1
THE QUEEN'S UNIVERSITY OF BELFAST1
THE SCOTTISH HUNTINGTON S ASSOCIATION1
THE UNIVERSITY OF SUSSEX1
UNIVERSIDAD COMPLUTENSE DE MADRID1
UNIVERSIDAD DE VALLADOLID1
UNIVERSITA DEGLI STUDI DI SASSARI1
UNIVERSITA VITASALUTE SAN RAFFAELE1
UNIVERSITAET ZUERICH1
UNIVERSITATSKLINIKUM ERLANGEN1
UNIVERSITY COLLEGE DUBLIN NATIONAL UNIVERSITY OF IRELAND DUBLIN1
UNIVERSITY COLLEGE LONDON HOSPITALSNHS FOUNDATION TRUST1
UNIVERSITY OF ABERDEEN1
UNIVERSITY OF BOLOGNA1
UNIVERSITY OF NEWCASTLE UPON TYNE1
UNIVERSITY OF NORTHUMBRIA AT NEWCASTLE1
UNIVERSITY OF READING1
WATERFORD INSTITUTE OF TECHNOLOGY1
WGK CONSULTANCY1
XENOPAT SL1
ZECLINICS SL1

Constancy:

Total number of partners: 93
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 93
Frequent / Rare Partner Ratio: 0

Project overview: